The HIV Vaccine Trials Network (HVTN) is an international collaboration of scientists and educators facilitating the development of HIV/AIDS preventive vaccines. The HVTN conducts all phases of clinical trials, from evaluating experimental vaccines for safety and immunogenicity, to testing vaccine efficacy. Over the past decade, the HVTN has aimed to improve the process of designing, implementi...

The pandemic caused by the new coronavirus infection remains topical health issue and constitutes serious threat to entire world. Nowadays, active immunization against type of continues in Russian Federation all other countries. Vaccination is crucial component comprehensive program for COVID-19 prevention control. Mass population can prevent both admissions hospitalization conditions high inci...

The emergence of Zika virus in the Americas and Caribbean created an urgent need for vaccines to reduce transmission and prevent disease, particularly the devastating neurodevelopmental defects that occur in utero. Rapid advances in Zika immunity and the development of vaccine candidates provide cautious optimism that preventive measures are possible.

Method To improve vaccine supply chain management in Mozambique a Dedicated Logistics System (DLS) was trialled. This system works through providing dedicated personnel to consolidate supply chain functions at the provincial level where limited resources are more likely to be available. These dedicated personnel distribute vaccines directly to health centres based on actual consumption, collect...

The adolescent period heralds the pediatric patient's transition into adulthood. It is a time of dynamic development during which effective preventive care measures can promote safe behaviors and the development of lifelong health habits. One of the foundations of preventive adolescent health care is timely vaccination, and every visit can be viewed as an opportunity to update and complete an a...

The burden of disease associated with Streptococcus pneumoniae infection in adults can be considerable but is largely preventable through routine vaccination. Although substantial progress has been made with the recent licensure of the new vaccines for prevention of pneumonia in adults, vaccine uptake rates need to be improved significantly to tackle adult pneumococcal disease effectively. Incr...

In the United States, eradication and reduction of vaccine-preventable diseases through immunization has directly increased life expectancy by reducing mortality. Although immunization is a public priority, vaccine coverage among adult Americans is inadequate. The Institute of Medicine, the Community Preventive Services Task Force, and other public health entities have called for the developmen...

After a year of the COVID-19 pandemic, meta-analysis in Dec 2020 did not support its reinfections. Now it’s clear that only reinfection following earlier exposure is reality, but also breakthrough infections after vaccinations have been increasingly reported. A infection means has broken through protection provided by vaccine. The course disease, strict observation for preventive measures, toge...

Human papillomaviruses (HPVs) are responsible for an enormous global burden of genital disease. HPV is annually associated with 500,000 new cases of cervical cancer and 250,000 cervical cancer deaths worldwide. There are more than 130 HPV genotypes that have been recognized from various clinical lesions. HPV types 16 and 18 are found in the majority of cervical cancer cases. The association bet...

Vaccinations are recommended throughout life to prevent vaccine-preventable diseases and their sequelae. Adult vaccination coverage, however, remains low for most routinely recommended vaccines and well below Healthy People 2020 targets. In October 2012, the Advisory Committee on Immunization Practices (ACIP) approved the adult immunization schedule for 2013. Apart from influenza vaccination, w...